🇺🇸 FDA
Patent

US 11407712

Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α

granted A61KA61K31/10A61K31/277

Quick answer

US patent 11407712 (Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α) held by Arcus Biosciences, Inc. expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arcus Biosciences, Inc.
Grant date
Tue Aug 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/10, A61K31/277, A61K31/343, A61K31/353